Vall d’Hebron University Hospital, Barcelona
Patricia Pozo-Rosich MD PhD, is a specialist in Neurology.
She is in charge of the Headache and Craniofacial Pain Clinical Unit and the Director of the Migraine Adaptive Brain Center at the Vall d’Hebron University Hospital in Barcelona, Spain; and the Group Leader and Principal Investigator of the Headache Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which belongs to the Universitat Autonoma of Barcelona (UAB).
She is the past Coordinator of the Spanish Headache Study Group of the Spanish Neurological Society (cefaleas.sen.es), she is a member of the Board of Trustees of the International Headache Society, the Council of the European Headache Federation and the Scientific Advisory Board of the Fundación Lilly Spain and the Migraine Research Foundation.
She is the Editor for Headache for Revista de Neurologia, an Associate Editor of Cephalalgia, Headache, Neurologia, Frontiers in Neurology (Headache Medicine) and a member of the Editorial Advisory Board of The Journal of Headache and Pain.
She has edited Guidelines for the Diagnosis and Treatment of Headache and written a book.
Dr Pozo-Rosich’s research focuses on better understanding the pathophysiology of migraine from a multidisciplinary approach using genetics, neuroimaging and electrophysiology. She has developed the Migraine Adaptive Brain research program. In this regard, she is a member of the International Headache Genetics Consortium. She has been awarded research grants from the la Caixa Foundation, Fondo de Investigaciones Sanitarias (ISCIII), ERANet Neuron, PERIS grant, FEDER, la Marató TV3 Foundation, International Headache Society, AGAUR, Mutual Medica and, the Migraine Research Foundation; as well as from Allergan and Novartis.
She has been the principal investigator of more than 25 clinical trials in phases II and III.
She educates neurologists, other physicians and patients with the goal of improving the quality of life of patients suffering from headache and helping reduce the stigma of migraine.
She is the founder and developer of the website in Spanish dedicated to headache www.midolordecabeza.org for patients and physicians which has more than 7,700 registered users and more than 25,000 facebook followers.
"Employment: Catalan Health Government – Vall d’Hebron University Hospital
Society Leadership/Board position: Scientific Advisory Board of Migraine Research Foundation & Lilly Foundation Spain, Member of the Council of the European Headache Federation
Professional membership: Sociedad Española Neurologia, American Headache Society
Personal fees: Honoraria as a consultant and participated in advisory boards for Allergan/AbbVie, Amgen, Almirall, Biohaven, Chiesi, Eli Lilly, Novartis, Teva Pharmaceuticals. Medical
Education projects with Allergan/AbbVie, Almirall, Chiesi, Eli Lilly, Medlink, Medscape, Neurodiem, Novartis, Teva Pharmaceuticals;
Research support: AGAUR, EraNet NEURON, La Caixa Foundation, Instituto Investigación Carlos III, Migraine Research Foundation; MINECO, Mutual Medica, PERIS, Abbvie, Novartis, Teva Pharmaceuticals (all to institution)
Clinical trials involvement: PI for over 30 clinical trials (phase II, III and IV) for teh preventive treatment of migraine and other headaches
Relationship with scientific journals: Associate Editor for Cephalalgia, Headache, Neurologia, Director for Headache Section of Revista de Neurologia; Editorial Advisor for Journal of Headache and Pain"